Opportunity Information: Apply for PAR 13 317
Apply for PAR 13 317
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394 Cancer Detection and Diagnosis Research.
- This funding opportunity was created on Aug 7, 2013 and posted on Aug 7, 2013.
- Applicants must submit their applications by Dec 11, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) State governments Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities County governments Special district governments Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
PAR 13 317, titled "Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01)," is a National Institutes of Health discretionary grant opportunity designed specifically for investigators who already hold an active NIH P01 (Program Project) award in a relevant area. Rather than funding brand-new standalone program projects, this announcement supports revision applications (previously called competing revisions) that add a substantial new research component to an existing, currently funded P01. The central goal is to accelerate progress in cancer screening, early detection, and diagnostic improvement by encouraging research that deliberately combines advanced imaging with biomarker science in an integrated, multi-disciplinary way.
The scientific emphasis is on integrated approaches that pair multi-modality imaging strategies with multiplexed biomarker methodologies. In practical terms, applicants are expected to propose work that brings together complementary technologies, such as combining different imaging modalities and pairing them with biomarker panels or high-throughput assays, to improve how cancers are detected earlier and more accurately. The intent is not simply to add another incremental aim, but to propose a new research project that meaningfully expands the scope of the parent P01 while still staying aligned with its overarching theme and purpose. The revision must fit within the context of what the parent program project is already doing, but it should clearly extend capabilities, collaborations, or scientific directions in a way that strengthens the overall program.
This FOA falls under the NIH activity category of Health and Education and is associated with CFDA number 93.394 (Cancer Detection and Diagnosis Research). It does not require cost sharing or matching, which reduces the financial burden on applicants and focuses review more on scientific merit and programmatic fit. The award ceiling listed is $150,000, indicating a capped amount available for the revision component supported through this mechanism.
Eligibility is broad across many U.S.-based organization types, but it is constrained by the requirement that applicants must be currently funded NIH P01 program projects and must be submitting a revision to that active award. Eligible applicant organizations include for-profit entities (including small businesses and other than small businesses), nonprofit organizations (including those with and without 501(c)(3) status, other than institutions of higher education), public and private institutions of higher education, and various levels of government (state, county, city/township, special district governments, independent school districts), as well as public housing authorities/Indian housing authorities. The announcement also explicitly includes a range of institution types and community-based entities as eligible, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with eligible federal government agencies, faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and certain tribal governments and tribal organizations. At the same time, it is clear that foreign institutions are not eligible, and non-U.S. components of U.S. organizations are also not eligible. In addition, foreign components as defined by the NIH Grants Policy Statement are not allowed, which keeps the supported work fully within allowable domestic boundaries.
Key administrative dates show the opportunity was posted and created on August 7, 2013, with an original and final closing date of December 11, 2015, and an archive date of January 11, 2016. That timeline indicates this was a time-limited funding announcement and is now archived, but the summary remains useful for understanding what NIH sought to encourage during the active period: tightly integrated imaging-plus-biomarker projects added onto existing P01 programs to push forward early cancer detection research.
For full details, NIH provided an additional information link to the complete FOA text at http://grants.nih.gov/grants/guide/pa-files/PAR-13-317.html. For technical difficulties accessing the announcement, the listed contact was the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV, which reflects that this entry was distributed through the federal opportunity posting infrastructure and NIH grants guide systems.
Frequently Asked Questions (FAQs)
What is PAR-13-317?
PAR-13-317 is a National Institutes of Health (NIH) discretionary grant opportunity titled "Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01)." It is designed to support revision applications to existing, active NIH P01 (Program Project) awards in relevant research areas.
Is this opportunity meant for brand-new P01 program projects?
No. This announcement is not intended to fund new standalone P01 awards. It supports revision applications (previously called competing revisions) that add a substantial new research component to an already funded, currently active P01.
Who is the intended applicant for this funding?
The intended applicants are investigators and organizations that already hold an active NIH P01 award and are submitting a revision to that active parent award.
What is a "revision application" in the context of this FOA?
In this FOA, a revision application is a request to add a substantial new research component to an existing, funded P01 program project. It is not meant to be an incremental add-on, but rather a meaningful expansion that strengthens the overall program while staying aligned with the parent P01's theme and purpose.
What is the main goal of PAR-13-317?
The central goal is to accelerate progress in cancer screening, early detection, and diagnostic improvement by encouraging integrated, multi-disciplinary research that deliberately combines advanced imaging with biomarker science.
What scientific approaches does this FOA emphasize?
The FOA emphasizes integrated approaches that pair multi-modality imaging strategies with multiplexed biomarker methodologies. Applicants are expected to propose work that combines complementary technologies, such as multiple imaging modalities along with biomarker panels or high-throughput assays, to improve earlier and more accurate cancer detection.
Does the new work need to align with the parent P01?
Yes. The revision must fit within the context of what the parent P01 program project is already doing and remain aligned with its overarching theme and purpose, while clearly expanding scope, capabilities, collaborations, or scientific direction.
What NIH activity category is associated with this funding opportunity?
This FOA falls under the NIH activity category of Health and Education.
What CFDA number is associated with PAR-13-317?
The associated CFDA number is 93.394, listed as Cancer Detection and Diagnosis Research.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
What is the award ceiling for this revision opportunity?
The award ceiling listed for the revision component supported through this mechanism is $150,000.
What types of U.S. organizations are eligible to apply?
Eligibility is broad across many U.S.-based organization types, as long as the applicant has an active NIH P01 and is submitting a revision to that award. Eligible organization types listed include for-profit entities (small businesses and other than small businesses), nonprofit organizations (with or without 501(c)(3) status, other than institutions of higher education), public and private institutions of higher education, and multiple levels of government entities (state, county, city/township, special district governments, independent school districts), plus public housing authorities/Indian housing authorities.
Are minority-serving institutions and community-based entities included as eligible applicants?
Yes. The opportunity explicitly includes a range of institution types and community-based entities as eligible, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also lists faith-based or community-based organizations and regional organizations among eligible applicants.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed among eligible applicants.
Are tribal governments and tribal organizations eligible?
Yes. The eligibility list includes certain tribal governments and tribal organizations.
Are federal government agencies eligible to apply?
Yes. Eligible federal government agencies are explicitly included in the list of eligible applicants.
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible under this announcement.
Can a U.S. organization include a non-U.S. component in the project?
No. Non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed. The supported work must remain within allowable domestic boundaries described in the announcement.
When was PAR-13-317 posted, and what were the key dates?
The opportunity was posted and created on August 7, 2013. The original and final closing date was December 11, 2015. The archive date was January 11, 2016.
Is this funding opportunity still open?
No. Based on the provided dates, the FOA was time-limited and is now archived (archive date: January 11, 2016), with a final closing date of December 11, 2015.
Where can someone find the full FOA text?
NIH provided a link to the complete FOA text here: http://grants.nih.gov/grants/guide/pa-files/PAR-13-317.html
Who was listed as a contact for technical difficulties accessing the announcement?
For technical difficulties accessing the announcement, the listed contact was the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
What is the overall theme of the research encouraged by this FOA?
The overall theme is to strengthen early cancer detection research by adding a substantial, integrated imaging-plus-biomarker research component to an existing P01 program project, using complementary technologies in a multi-disciplinary way to improve screening, early detection, and diagnostic accuracy.
Browse more opportunities from the same category: Education Health
Next opportunity: Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50)
Previous opportunity: Public Opinion Polling Project
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 317
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 317) also looked into and applied for these:
| Funding Opportunity |
|---|
| Revision Applications to P50 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P50) Apply for PAR 13 318 Funding Number: PAR 13 318 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| National Cancer Institute Program Project Applications (P01) Apply for PAR 13 321 Funding Number: PAR 13 321 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Increased Knowledge and Innovative Strategies to Reduce HIV IncidenceiKnow Projects (R01) Apply for PAR 13 323 Funding Number: PAR 13 323 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR R43/44) Apply for PAR 13 327 Funding Number: PAR 13 327 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Revisions for Early Stage Development of Informatics Technology (P01) Apply for PAR 13 330 Funding Number: PAR 13 330 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R21) Apply for PA 13 331 Funding Number: PA 13 331 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) Apply for PAR 13 334 Funding Number: PAR 13 334 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,000,000 |
| Neuroscience Research on Drug Abuse (R21) Apply for PA 13 337 Funding Number: PA 13 337 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Neuroscience Research on Drug Abuse (R03) Apply for PA 13 336 Funding Number: PA 13 336 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Neuroscience Research on Drug Abuse (R01) Apply for PA 13 338 Funding Number: PA 13 338 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R01) Apply for PA 13 339 Funding Number: PA 13 339 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanisms of Alcohol and Stimulant Co Addiction (R21) Apply for PA 13 340 Funding Number: PA 13 340 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Early Career Award in Chemistry of Drug Abuse and Addiction (ECHEM) (R21/R33) Apply for PAR 13 350 Funding Number: PAR 13 350 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| National Institute on Drug Abuse National Early Warning System (NEWS) Coordinating Center (U01) Apply for RFA DA 14 015 Funding Number: RFA DA 14 015 Agency: National Institutes of Health Category: Education Health Funding Amount: $900,000 |
| Research Answers to NCIs Provocative Questions Group A (R01) Apply for RFA CA 13 016 Funding Number: RFA CA 13 016 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group A (R21) Apply for RFA CA 13 017 Funding Number: RFA CA 13 017 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions Group B (R01) Apply for RFA CA 13 018 Funding Number: RFA CA 13 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group C (R01) Apply for RFA CA 13 020 Funding Number: RFA CA 13 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R01) Apply for RFA CA 13 022 Funding Number: RFA CA 13 022 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions Group D (R21) Apply for RFA CA 13 023 Funding Number: RFA CA 13 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 317", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.